Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Que savons-nous de la toxicité récréative du protoxyde d’azote ? Une réponse des Hauts-de-France

Autor: Deheul, S., Béné, J., Karam, A., Gras, V., Masmoudi, K., Gautier, S., Tard, C., Hoornaert, O., Lebouvier, T., Simonin, C., Ménard, O., Caous, A.S., Nisse, P., Meguig, S., Tison, J., Azzouz, R., Carton, L.

Publikováno v: Toxicologie Analytique et Clinique; March 2021, Vol. 33 Issue: 1 p28-28, 1p

Modifying effect of ceruloplasmin polymorphism on iron chelation response in Parkinson's disease

Autor: Grolez, G., Meguig, S., Moreau, C., Sablonniere, B., Strubi-Vuilhaume, I., Ryckewaert, G., Jissendi, P., Hopes, L., Dujardin, K., Devedjian, J. C., Kluza, J., Jonneaux, A., Petrault, M., Garcon, G., Rouaix, N., Duhamel, A., Auger, F., Ravasi, L., Firdaus, W., Zahr, N., Destee, A., jean-christophe corvol, Poeltl, D., Leist, M., Rose, C., Marchetti, P., Cabantchik, I. Z., Bordet, R., Defebvre, L., Devos, D.

Publikováno v: Publons
ResearcherID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::506a858f08e3a6af6e24faf181f18cb1
https://publons.com/publon/27024941/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.

Autor: Grolez G; Department of Movement Disorders and Neurology, Lille Nord de France University, Lille, France. guillaume.grolez2@chru-lille.fr.; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. guillaume.grolez2@chru-lille.fr., Moreau C; Department of Movement Disorders and Neurology, Lille Nord de France University, Lille, France. caroline.moreau@chru-lille.fr.; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. caroline.moreau@chru-lille.fr., Sablonnière B; Department of Molecular Biology and Pathology Centre, Unit 837, Team 1, INSERM Lille Faculty of Medicine, Lille University Hospital, Lille Nord de France University, Lille, France. bernard.sablonniere@inserm.fr., Garçon G; Department of Toxicology, Public Health and Environment, EA 4483, Faculty of Pharmaceutic and Biological Sciences, Lille Nord de France University, Lille, France. guillaume.garcon@univ-lille2.fr., Devedjian JC; Department of Medical Pharmacology, Lille Nord de France University, Lille, France. Jean-Christophe.Devedjian@univ-littoral.fr.; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. Jean-Christophe.Devedjian@univ-littoral.fr., Meguig S; Department of Medical Pharmacology, Lille Nord de France University, Lille, France. sayahmeguig@hotmail.fr., Gelé P; Biological Resources Centre, Lille University Hospital, Lille, France. patrick.gele@univ-lille2.fr., Delmaire C; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. christine.chd@gmail.com.; Department of Neuroradiology, Lille University Hospital, Lille, France. christine.chd@gmail.com., Bordet R; Department of Medical Pharmacology, Lille Nord de France University, Lille, France. regis.bordet@univ-lille2.fr.; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. regis.bordet@univ-lille2.fr., Defebvre L; Department of Movement Disorders and Neurology, Lille Nord de France University, Lille, France. luc.defebvre@chru-lille.fr.; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. luc.defebvre@chru-lille.fr., Cabantchik IZ; Della Pergola Chair, Alexander Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel. ioav.caban@mail.huji.ac.il., Devos D; Department of Medical Pharmacology, Lille Nord de France University, Lille, France. david.devos@chru-lille.fr.; Department of Movement Disorders and Neurology, Lille Nord de France University, Lille, France. david.devos@chru-lille.fr.; INSERM U1171, Lille Faculty of Medicine, Lille Nord de France University, Lille, France. david.devos@chru-lille.fr.; Department of Toxicology, Public Health and Environment, EA 4483, Faculty of Pharmaceutic and Biological Sciences, Lille Nord de France University, Lille, France. david.devos@chru-lille.fr.

Publikováno v: BMC neurology [BMC Neurol] 2015 May 06; Vol. 15, pp. 74. Date of Electronic Publication: 2015 May 06.